Listen to the following talks:

• Compare and Contrast Guidelines for Drug Development in RA and OA
  
• Overview of the Clinical Developments in the Field
• Regulatory Round Table
• Regulatory Understanding and Current Guidelines in the EU and US – Implications for OA Trial Design
• Most Common Reasons For Screen Failure In Clinical Trials Of Knee Osteoarthritis – Analysis Of Eight Phase II Trials